EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Past, present, and future of microbiome-based therapies

Pilar Manrique, Ignacio Montero, Marta Fernandez-Gosende, Noelia Martinez, Claudio Hidalgo Cantabrana, David Rios-Covian

Microbiome Research Reports · 18.03.2024 · 3 (2)

DOI: 10.20517/mrr.2023.80 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Microbiome Research Reports, online erschienen am 18.03.2024. Verfasst von Pilar Manrique und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of R&D, Microviable Theapeutics S.L., Gijón 33203, Spain. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 175 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Technological advances in studying the human microbiome in depth have enabled the identification of microbial signatures associated with health and disease. This confirms the crucial role of microbiota in maintaining homeostasis and the host health status. Nowadays, there are several ways to modulate the microbiota composition to effectively improve host health; therefore, the development of therapeutic treatments based on the gut microbiota is experiencing rapid growth. In this review, we summarize the influence of the gut microbiota on the development of infectious disease and cancer, which are two of the main targets of microbiome-based therapies currently being developed. We analyze the two-way interaction between the gut microbiota and traditional drugs in order to emphasize the influence of gut microbial composition on drug effectivity and treatment response. We explore the different strategies currently available for modulating this ecosystem to our benefit, ranging from 1st generation intervention strategies to more complex 2nd generation microbiome-based therapies and their regulatory framework. Lastly, we finish with a quick overview of what we believe is the future of these strategies, that is 3rd generation microbiome-based therapies developed with the use of artificial intelligence (AI) algorithms.

Schlagwörter

Stichwörter der Autor:innen

LBPMBPMicrobiome-based therapiesbiological drugsmicrobiota

Autor:innen und Institutionen

  • Department of R&D, Microviable Theapeutics S.L., Gijón 33203, Spain.

Zitieren

APA

Manrique, P., Montero, I., Fernandez-Gosende, M., Martinez, N., Cantabrana, C. H., & Rios-Covian, D. (2024). Past, present, and future of microbiome-based therapies. Microbiome Research Reports, 3(2). https://doi.org/10.20517/mrr.2023.80

Vancouver

Manrique P, Montero I, Fernandez-Gosende M, Martinez N, Cantabrana CH, Rios-Covian D. Past, present, and future of microbiome-based therapies. Microbiome Research Reports. 2024;3(2). doi:10.20517/mrr.2023.80

BibTeX
@article{Manrique2024,
  author = {Manrique, Pilar and Montero, Ignacio and Fernandez-Gosende, Marta and Martinez, Noelia and Cantabrana, Claudio Hidalgo and Rios-Covian, David},
  title = {Past, present, and future of microbiome-based therapies},
  journal = {Microbiome Research Reports},
  year = {2024},
  volume = {3},
  number = {2},
  doi = {10.20517/mrr.2023.80}
}
Kostenlos starten →